CPL, a contract development and manufacturing organization (CDMO) of non-sterile liquid and topical drug products, recently discussed its approach to topical drug development and how it is supporting its customers with these new services. Brian Lankadurai, Ph.D., Senior Director of Product Development, outlined how CPL’s integrated approach to topical drug development can save its customers time and cost.   “In topical drug development the biggest challenge is to get the drug through the skin ...